1 Osteogenesis imperfecta (OI) is a genetic disorder that affects all connective tissue.

2 Lin Yu-chih, an Osteogenesis Imperfecta patient who measures 67.5 centimeters in height, performs a stage play during a news conference July 10, 2007, to urge public awareness of the disease.

3 Osteogenesis imperfecta(OMIM 166200)is an autosomal dominant disorder characterized by bone fragility and abnormalities of connective tissue.

4 Objective To summarize the experience of pamidronate for osteogenesis imperfecta.

5 Osteogenesis imperfecta is an inherited disorder of connective tissue, which affects the skeleton, ligament, skin, sclera, and dentin.

6 Study Design. We report 2 cases of acute cervical compression fracture in patients with osteogenesis imperfecta (OI).

7 Objective:To introduce the clinical and radiological findings of the tumoral callus in osteogenesis imperfecta and to describe its probable formative mechanism.

8 Methods To review the effect of intravenous pamidronate therapy on two patients with osteogenesis imperfecta in 2007.

9 The 35-year-old from Dry Ridge, Kentucky, USA, suffers from Osteogenesis Imperfecta, which causes brittle bones and underdeveloped lungs, and means she failed to grow.

10 After diagnosis, she was suffering from the rare "typical osteogenesis imperfecta", which is the first in the Southwest fairly.

11 Objective To discuss the X - ray appearances of osteogenesis imperfecta.

12 We report a case of hyperplastic callus formation that occurred in both femurs in a patient with type V osteogenesis imperfecta (OI),[] with 4-year follow-up and resolution.

13 Objective To evaluate the diagnostic value of X-ray in osteogenesis imperfecta of fetus.

14 Purpose To investigate the main points of diagnosing hereditary osteogenesis imperfecta.

15 Conclusion Pamidronate therapy has a positive effect on patients with osteogenesis imperfecta, while this still remains to be demonstrated in more patients with osteogenesis imperfecta.